Exclusive weekly insights for sharemarket success.
Tim Lincoln, Co-Founder and Chief Investment Officer, and Matt Swartz, Senior Portfolio Manager, will join the conversation once a month to share their passion and strategy for Lincoln Indicator’s Managed Funds, as well as their insights for investors.
Join Kien Trinh, Head of Research and Daniel Ortisi, Equities Analyst as they take you through the recent confession season, highlighting the vulnerabilities in the market.
Stocks discussed include BHP Group (BHP), IPD Group (IPG), Neuren Pharmaceuticals (NEU) and Xero (XRO).
The pair conclude by discussing why earnings revisions is an important criteria when selecting stocks.
Sit back and enjoy the conversation.
Experience Stock Doctor yourself by taking a FREE trial today.
To discuss the future of your investments in detail, book in a free consultation with a Lincoln representative.
To discuss the future of your investments in detail, book in a free consultation with a Lincoln financial expert.